Home / Investors / Startups / Clade Therapeutics

Clade Therapeutics

Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.

About Clade Therapeutics

Clade Therapeutics is a biopharmaceutical company focused on discovering and delivering scalable, off-the-shelf, next-generation stem-cell-based medicines. The company was incorporated in 2020 and has been operating in Cambridge, Massachusetts, United States.

Industries

Investors in Clade Therapeutics (4)